TP53 and neoplasm: By identifying a new p53 acetylation site at lysine K136, mutations at all five acetylation sites (p53-5KR) completely/greatly reduced the remaining tumour suppressive function of p53104,105, which indicates that p53 acetylation plays an important role in regulating ferroptosis and inhibiting tumour development.